Insights & Publications
© 2018 Debevoise & Plimpton LLP
U.S. Federal Court Denies Immunity to Sovereign Wealth Funds
26 February 2016
View Client Update
The U.S. Foreign Sovereign Immunities Act (“FSIA”) applies to securities fraud claims brought against sovereign wealth funds in the United States.
Sovereign wealth funds are immune from suit in the United States unless one of the exceptions set forth in the FSIA applies.
There will be no immunity from suit when misrepresentations made in connection with the funds’ commercial activity outside the United States cause economic harm to investors in the United States.
Arbitration & International Disputes
Investment Management Litigation
Sovereign Wealth Investors
Mark W. Friedman
Debevoise Announces New Funds Regulatory Counsel in London
European Funds Comment: Private Equity and European Competition Law
Debevoise Partner Patricia Volhard Joins Panelists to Discuss New Opportunities and Challenges for Investors
European Funds Comment: UK Government Adapts Proposals to Reform Law on Insolvency and Corporate Governance
UK Modern Slavery Act Transparency Statement
Debevoise Women's Review